• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Infectious Disease

Meningococcus B rates higher among college students compared with noncollege peers

byKate AndersonandLeah Carr, MD
January 6, 2019
in Infectious Disease, Pediatrics, Public Health
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. College students were at significantly higher risk of contracting meningococcus serotype B (MenB) disease compared with noncollege students in the same age group.

2. Less than 25% of college students who contracted meningococcal disease had received at least one dose of the MenB vaccine.

Study Rundown: While the overall incidence of meningococcal disease is low in the United States (US), and has been decreasing for the past 3 decades, studies conducted prior to the licensing of several meningococcal vaccines suggest infection rates are higher among college students living in dormitories. While 2 vaccines (one covering bacterial serotype B [MenB] and one covering serotypes ACWY [MenACWY]) are currently recommended for populations at increased risk, MenB vaccine coverage has been estimated to be <10% among 16 to 18-year-olds.1 In this study, investigators analyzed data collected from a national surveillance system to evaluate the relative risk (RR) of meningococcal disease among college versus noncollege students aged 18 to 24 years. Serotype data was also obtained and described in this report. Results showed an overall low incidence of meningococcal disease in this age group and almost 60% of cases caused by the MenB serotype. College students had a significantly greater risk of contracting MenB compared with noncollege persons, and were significantly more likely to have received at least one dose of the MenACWY vaccine. Less than one-fourth of college students and one-fifth of noncollege persons with meningococcal disease received at least a single dose of the MenB vaccine. This study is limited by lack of data on risk factors related to meningococcal disease or carriage among college students. Results of this study suggest the need for increased patient education surrounding the increased risk of MenB among college students and the availability of the MenB vaccine.

Click to read the study, published today in Pediatrics

Click to read accompanying commentary in Pediatrics

Recommended reading: Risk factors for meningococcal disease in college students

In-depth [epidemiologic study]: Investigators evaluated data from the US National Notifiable Diseases Surveillance System (NNDSS) to describe the epidemiology and RR of meningococcal disease among college students versus noncollege students aged 18 to 24 years from 2014 to 2016. Serotype analysis isolates was performed on disease-causing isolates from cases that occurred in 45 states (98% of the US population. Of the 1174 confirmed cases of meningococcal disease, 166 (14.1%) occurred in people aged 18 to 24 years, 83 of whom (50.9%) were college students. The overall annual incidence of meningococcal disease in this age group was 0.17 per 100 000. MenB was the most common serotype overall (88 cases, 58.3%) and college students had a significantly higher risk of contracting MenB compared with noncollege persons (RR 3.54, 95%CI 2.21-5.41). The combined incidence of other serotypes (C, W, Y) was similar among college and noncollege persons (0.03 cases vs. 0.05 cases per 100 000 respectively; RR 0.56, 95%CI 0.27 – 1.14). MenB outbreaks were reported only among college students and accounted for 31.7% of the MenB cases in this group. College students were significantly more likely to have received at least one dose of the MenACWY vaccine compared with noncollege persons (86.9% vs. 39.6% respectively, p < .01) while there was no difference in MenB vaccine rates (22.9% vs. 17.5% respectively, p > .99). Disease outcomes were similar among college vs. noncollege students (mortality 13.0% vs. 11.8% respectively, p = .83).

RELATED REPORTS

Inactivated, adjuvant enterovirus 71 vaccine is safe and effective against fatal enterovirus infections in children aged 2-71 months

Vaccination leads to a small absolute risk for shoulder conditions

Testing for sexually transmitted infections is infrequent among high school students in the United States

1. MacNeil JR, Blain AE, Wang X, Cohn AC. Current epidemiology and trends in meningococcal disease-United States, 1996-2015. Clin Infect Dis. 2018;66(8):1276–1281

Image: PD

©2019 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: adolescent medicinebacterial meningitisvaccination
Previous Post

The VITAL trial: Omega-3 supplementation does not reduce risk of cardiovascular events

Next Post

#VisualAbstract: Mupirocin for Staphylococcus aureus Decolonization of Infants in Neonatal Intensive Care Units

RelatedReports

Preterm infants responsive to PCV13 vaccine
Infectious Disease

Inactivated, adjuvant enterovirus 71 vaccine is safe and effective against fatal enterovirus infections in children aged 2-71 months

May 10, 2022
Medical vaccine exemptions increase after elimination of nonmedical exemptions
Chronic Disease

Vaccination leads to a small absolute risk for shoulder conditions

April 22, 2022
AAP opposes school-based drug testing of adolescents
Chronic Disease

Testing for sexually transmitted infections is infrequent among high school students in the United States

April 11, 2022
Quick Take: The clinical effectiveness of sertraline in primary care and the role of depression severity and duration (PANDA): a pragmatic, double-blind, placebo-controlled randomized trial
Chronic Disease

Barriers to medication access for opioid use disorder in adolescents and young adults

April 4, 2022
Next Post
#VisualAbstract: Mupirocin for Staphylococcus aureus Decolonization of Infants in Neonatal Intensive Care Units

#VisualAbstract: Mupirocin for Staphylococcus aureus Decolonization of Infants in Neonatal Intensive Care Units

Strict tobacco licensing laws linked to reduced adolescent smoking initiation

Strict tobacco licensing laws linked to reduced adolescent smoking initiation

The RECIST 1.1 trial: Measuring tumor burden to assess response to therapy [Classics Series]

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

Get 2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • #VisualAbstract: Bimekizumab shows a favourable 2-year safety profile in patients with moderate to severe plaque psoriasis
  • Medical cannabis provides little improvement to sleep in chronic pain patients
  • Alzheimer disease in individuals with Down syndrome has similar variability in age of onset and mortality rate as autosomal dominant forms
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.